Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non-small cell lung cancer. | J Pathol Transl Med | 2021 | 34147056 | PubTator, text mining | PubMed |
| SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer. | Oncogene | 2021 | 34140644 | PubTator, text mining | PubMed |
| Advancing targeted protein degradation for cancer therapy. | Nat Rev Cancer | 2021 | 34131295 | PubTator, text mining | PubMed |
| Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells. | Oncogene | 2021 | 34127815 | PubTator, text mining | PubMed |
| SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing. | Genes Chromosomes Cancer | 2021 | 34124809 | PubTator, text mining | PubMed |
| SWI/SNF-deficient undifferentiated/rhabdoid carcinoma of the gallbladder carrying a POLE mutation in a 30-year-old woman: a case report. | Diagn Pathol | 2021 | 34118935 | PubTator, text mining | PubMed |
| Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature. | Ann Diagn Pathol | 2021 | 34111706 | PubTator, text mining | PubMed |
| Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras. | J Med Chem | 2021 | 34106704 | PubTator, text mining | PubMed |
| Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics. | Int J Med Sci | 2021 | 34104084 | PubTator, text mining | PubMed |
| Proteomic analysis of bone marrow-derived mesenchymal stem cell extracellular vesicles from healthy donors: implications for proliferation, angiogenesis, Wnt signaling, and the basement membrane. | Stem Cell Res Ther | 2021 | 34090527 | PubTator, text mining | PubMed |
| Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. | Nat Cancer | 2021 | 34085048 | PubTator, text mining | PubMed |
| The unique molecular mechanism of diabetic nephropathy: a bioinformatics analysis of over 250 microarray datasets. | Clin Kidney J | 2021 | 34084458 | PubTator, text mining | PubMed |
| BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4. | Sci Rep | 2021 | 34083693 | PubTator, text mining | PubMed |
| Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy. | Antiviral Res | 2021 | 34082058 | PubTator, text mining | PubMed |
| Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia. | ACS Cent Sci | 2021 | 34079898 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. | Mod Pathol | 2021 | 34079072 | PubTator, text mining | PubMed |
| The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective. | Cancers (Basel) | 2021 | 34071216 | PubTator, text mining | PubMed |
| Sophisticated Conversations between Chromatin and Chromatin Remodelers, and Dissonances in Cancer. | Int J Mol Sci | 2021 | 34070411 | PubTator, text mining | PubMed |
| The Effect of RBP4 on microRNA Expression Profiles in Porcine Granulosa Cells. | Animals (Basel) | 2021 | 34068244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=55